Back
Corcept Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
74
CORT
Corcept Therapeutics
Last Price:
47.26
Seasonality Move:
4.91%
Sell
48
ALNY
Alnylam Pharmaceuticals
Last Price:
293.69
Seasonality Move:
13.96%
Buy
74
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $48.06. The Score for CORT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $294.87. The Score for ALNY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $48.06
The current trend is moderately bullish and CORT is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $294.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.32 | Buy |
| Relative Strength Index (14 RSI): | 65.48 | Buy |
| Chaikin Money Flow: | -321908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.12 - 47.58) | Buy |
| Bollinger Bands (100): | (30.83 - 42.11) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.38 | Buy |
| Relative Strength Index (14 RSI): | 64.82 | Buy |
| Chaikin Money Flow: | -134342 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (268.97 - 288.67) | Buy |
| Bollinger Bands (100): | (205.28 - 288.6) | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.59 | Buy |
| 20-day SMA: | 46.07 | Buy |
| 50-day SMA: | 40.24 | Buy |
| 200-day SMA: | 30.44 | Buy |
| 8-day EMA: | 47.77 | Buy |
| 20-day EMA: | 45.77 | Buy |
| 50-day EMA: | 41.67 | Buy |
| 200-day EMA: | 33.37 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 291.86 | Buy |
| 20-day SMA: | 280.23 | Buy |
| 50-day SMA: | 272.87 | Buy |
| 200-day SMA: | 202.62 | Buy |
| 8-day EMA: | 290.88 | Buy |
| 20-day EMA: | 282.91 | Buy |
| 50-day EMA: | 270.29 | Buy |
| 200-day EMA: | 222.75 | Buy |
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.76 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.77 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.32 per share, and an increase next year of $0.75 per share.
Corcept Therapeutics Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||